Is Neximmune Inc (NEXI) Stock About to Get Hot Friday?

Neximmune Inc (NEXI) stock is down 2.69% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Neximmune Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on NEXI!

See Full NEXI Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With NEXI Stock Today?

Neximmune Inc (NEXI) stock is higher by 4.71% while the S&P 500 is down -1.26% as of 10:58 AM on Friday, Apr 22. NEXI has risen $0.13 from the previous closing price of $2.76 on volume of 48,790 shares. Over the past year the S&P 500 has gained 3.95% while NEXI is down -84.37%. NEXI lost -$2.54 per share in the over the last 12 months. To screen for more stocks like Neximmune Inc click here.

More About Neximmune Inc

NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ the body's T cells to generate an immune response that mimics natural biology. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. Click Here to get the full Stock Report for Neximmune Inc stock.